Home » GSK Drug Halves Attacks in Hard-to-Treat Asthma
GSK Drug Halves Attacks in Hard-to-Treat Asthma
An experimental drug for treating severe asthma from GlaxoSmithKline nearly halved the number of attacks suffered by patients with a hard-to-treat form of the disease in a clinical study, boosting hopes for its commercial success.
Reuters
Reuters
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May